Renew Research, LLC: Clinical Trials

1 trial sponsored by Renew Research, LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Renew Research, LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type
Renew NCP-5 - Alzheimer Disease, Cognitive Dysfunction
Phase 3CompletedRenew Research, LLC1902018-11-122022-05-11

Conditions studied

Alzheimer Disease (1)  ·  Cognitive Dysfunction (1)

Countries

Ireland (1)  ·  Singapore (1)  ·  United States (1)

Top investigators

Billy Tally (1)